Graphene oxide activates canonical TGFβ signalling in a human chondrocyte cell line via increased plasma membrane tension

  • 0Division of Cell Matrix Biology & Regenerative Medicine, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, M13 9PT, UK. sue.kimber@manchester.ac.uk.

|

|

Summary

This summary is machine-generated.

Graphene oxide (GO) enhances cartilage gene expression by increasing plasma membrane tension, activating mechanosensory pathways and latent TGFβ. This reveals a novel mechanism for GO

Area Of Science

  • Biomaterials Science
  • Regenerative Medicine
  • Cell Signaling

Background

  • Graphene oxide (GO) promotes chondrogenesis in 3D scaffolds, but its underlying mechanisms are unclear.
  • Understanding GO's chondroinductive effects is crucial for articular cartilage regeneration therapies.

Purpose Of The Study

  • To elucidate the effects of GO on the transforming growth factor-beta (TGFβ) signaling pathway in human chondrocytes.
  • To identify the specific mechanisms by which GO activates chondrogenic signaling.

Main Methods

  • Validation of canonical TGFβ signaling via SMAD-2 phosphorylation and gene expression analysis.
  • Utilized a TGFβ signaling reporter assay to determine the onset of GO-induced signal activation.
  • Employed fluorescent lifetime imaging (FLIM) and membrane tension probes to assess cell-material interactions in real-time.

Main Results

  • Demonstrated GO-induced SMAD-2 phosphorylation and upregulation of TGFβ response genes.
  • Identified a novel, real-time increase in plasma membrane tension mediated by GO.
  • Revealed activation of mechanosensory pathways and endogenous latent TGFβ in the presence of GO.

Conclusions

  • Graphene oxide activates chondrogenic signaling through increased plasma membrane tension and subsequent activation of latent TGFβ.
  • Established a novel link between GO, plasma membrane mechanics, and intracellular signaling pathways.
  • Provides critical insights into GO's chondroinductive properties for regenerative medicine applications.